Antares Pharma reported $17.06M in Trade Creditors for its fourth fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Trade Creditors Change
Adma Biologics ADMA:US $ 11.39M 2.73M
Aerie Pharmaceuticals AERI:US $ 9.28M 1.4M
Ani Pharmaceuticals ANIP:US $ 27.64M 5.58M
Cara Therapeutics CARA:US $ 9.74M 4.15M
Cerus CERS:US $ 29.36M 2.12M
Eli Lilly And LLY:US $ 1659.3M 226M
Endo International Ordinary Shares ENDP:US $ 90.64M 10.36M
Horizon Pharma HZNP:US $ 18.54M 48.48M
JAZZ PHA JAZZ:US $ 74.16M 0.82M
Meridian Bioscience VIVO:US $ 15.36M 0.32M
Orasure Technologies OSUR:US $ 36.23M 9.17M
Pacira Pharmaceuticals PCRX:US $ 13.98M 0.86M
Revance Therapeutics RVNC:US $ 13.27M 3.25M
Sientra SIEN:US 9.11M 1.71M
Staar Surgical STAA:US $ 12.72M 0.7M
Teva Pharmaceutical TEVA:IT 1.9B 151M
Teva Pharmaceutical Industries TEVA:US $ 1901M 151M
Utah Medical Products UTMD:US $ 818K 208K